ZPL389

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZPL389, covering 2021-07-20 to 2021-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients [Phase 2]